Collagen Or Derivative Affecting Or Utilizing Patents (Class 514/17.2)
-
Publication number: 20140011743Abstract: The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.Type: ApplicationFiled: September 11, 2013Publication date: January 9, 2014Applicant: Anthrogenesis CorporationInventors: Mohit Bhatia, Chris Lugo, Qian Ye, James W. Edinger
-
Publication number: 20140004158Abstract: Cell attachment coatings for articles such as implantable medical devices and cell culture vessels are disclosed. The coatings include an intermediate coater layer which includes a phosphorous-containing component that is bonded in the coating by reacted photoreactive functional groups. The coating also include a second coated layer including an immobilized ECM protein or peptide that includes an active portion of an ECM protein that is able to serve as an outer layer to contact cells during use. The coatings promoted enhanced cell binding and growth.Type: ApplicationFiled: June 28, 2013Publication date: January 2, 2014Inventor: Joseph S. McGonigle
-
Publication number: 20140005115Abstract: Provided herein are methods of treating, suppressing, inhibiting, or preventing bronchitis in a subject comprising the step of administering to a subject a compound comprising a lipid or phospholipid moiety bond to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof.Type: ApplicationFiled: March 7, 2013Publication date: January 2, 2014Applicant: YISSUM RESEARCH DEVELOPMENT COMPANYInventor: YISSUM RESEARCH DEVELOPMENT COMPAN
-
Publication number: 20130345140Abstract: The invention relates to cell support compositions comprising a basement membrane extract isolated from cardiac or smooth muscle. The invention also relates to methods of using the cell support compositions for supporting cellular functions.Type: ApplicationFiled: August 25, 2011Publication date: December 26, 2013Applicant: LifeNet HealthInventor: Roy Ogle
-
Publication number: 20130344166Abstract: A topical mixture intended to reduce undesirable Iron levels in the cells to optimize Mitochondrial functioning. A method of reducing undesirable levels of Iron in the cells to optimize Mitochondrial functioning.Type: ApplicationFiled: June 25, 2012Publication date: December 26, 2013Inventor: PIERRE ERNEST LOUBET
-
Publication number: 20130330417Abstract: Nanocellulose foams containing at least one active ingredient and methods of preparing such nanocellulose foams containing one or more active ingredients are provided herein. In some embodiments, a method for preparing nanocellulose foam containing active ingredients may include forming a liquid mixture of nanocellulose, wherein the nanocellulose is at least one of dispersed, suspended or gelled in the liquid mixture; drying the liquid mixture of nanocellulose to form a nanocellulose foam; and mixing at least one active ingredient into at least one of the liquid mixture of nanocellulose or the nanocellulose foam. In some embodiments, a nanocellulose structure may include a nanocellulose foam comprising at least one of a carboxylate group, a hydroxyl group, or a sulfate group bonded to an active ingredient. In some embodiments, the nanocellulose structures are enhanced or crosslinked with metal cations.Type: ApplicationFiled: June 7, 2013Publication date: December 12, 2013Inventors: Hong Dong, James F. Snyder
-
Patent number: 8603982Abstract: A medical composition is described in which a synthetic polymer substrate and a composition mainly composed of a biopolymer directly adhere to each other due to dissolution of the surfaces thereof. The medical composition allows one to attach a biopolymer composition to a synthetic polymer substrate without the use of a toxic adhesive.Type: GrantFiled: March 30, 2009Date of Patent: December 10, 2013Assignee: FUJIFILM CorporationInventors: Shouji Ooya, Kentaro Nakamura
-
Publication number: 20130323311Abstract: This invention relates to compositions comprising collagen binding peptides coupled to nanoparticles. The invention also relates to a method of imaging a collagenous matrix using a composition comprising collagen binding peptides coupled to nanoparticles.Type: ApplicationFiled: February 16, 2012Publication date: December 5, 2013Applicant: PURDUE RESEARCH FOUNDATIONInventors: John E. Paderi, Alyssa Panitch
-
Patent number: 8597717Abstract: Techniques for the production of flow-oriented collagen gels using hydrodynamics to influence the assembly of collagen fibers. Highly concentrated monomeric solutions of collagen are subjected to shear and extensional flow as they are drawn onto a substrate to induce fibrillogenesis under a high Ph buffer. The produced gel captures the flow induced ordering of molecular collagen upon fibril formation. The depositing or the induction of fibrillogenosis occurs without the application of a magnetic field to the concentration of collagen. These highly oriented 3D scaffolds are capable inducing contact guidance and guiding mammalian cell growth. The collagen fibers mimic the construction of in vivo fibers with the characteristic D-periodicity and the integrin receptors on the fibroblasts respond to this organization. The industrial applications of three-dimensional collagen gels as a biomaterial are widespread from drug delivery to burn repair or tissue engineering system.Type: GrantFiled: November 8, 2012Date of Patent: December 3, 2013Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Gerald G. Fuller, John E. Kirkwood
-
Publication number: 20130316950Abstract: Mimetic peptides having anti-angiogenic and anti-tumorigenic properties and methods of their use for treating cancer, ocular diseases, such as age-related macular degeneration, and other-angiogenesis-dependent diseases are disclosed. More particularly, active non-cysteine analogs (mimetics), which exhibit anti-angiogenic activity in endothelial cell proliferation, migration, adhesion, and tube formation assays, anti-migratory activity in human breast cancer cells in vitro, anti-angiogenic and anti-tumorigenic activity in vivo in breast cancer xenograft models, and age-related macular degeneration models are disclosed. The presently disclosed mimetic peptides also exhibit anti-lymphangiogenic and directly anti-tumorigenic properties.Type: ApplicationFiled: December 12, 2011Publication date: November 28, 2013Applicant: THE JOHNS HOPKINS UNIVERSITYInventors: Aleksander S. Popel, Elena V. Rosca, Jacob E. Koskimaki, Corban G. Rivera, Niranjan B. Pandey, Amir P. Tamiz
-
Publication number: 20130310322Abstract: Described are purified extracellular matrix materials isolated from the abdominal wall of animals and including the subserous fascia layer of the abdominal wall. Such medical materials can find use in treating damaged tissue and in certain aspects in providing tissue support for the repair of hernias. Related methods of manufacture and use are also described.Type: ApplicationFiled: July 26, 2013Publication date: November 21, 2013Inventors: Bhavin Shah, Katie L. Harrigan
-
Patent number: 8586070Abstract: The present invention relates to compositions devices and methods for treating bone and/or cartilage defects, and a method for manufacturing such a composition or device. In a certain embodiment, the invention provides a device and/or composition for treating bone and/or cartilage defects, having at least one collagen, for example of animal origin, and further containing at least one substance having an osteo-inductive or chondro-inductive activity, at least one differentiation and/or growth factor having osteo-stimulative and/or chondro-stimulative effect, and at least one filling material, in which the composition is in the form of a lyophil.Type: GrantFiled: January 24, 2012Date of Patent: November 19, 2013Assignee: SBF Synthetic Bone Factory GmbHInventor: Arne Briest
-
Publication number: 20130288973Abstract: A process for producing a decellularized small particle tissue which involves selecting an appropriate tissue starting material from which a decellularized small particle tissue is desired to be prepared, treating the tissue with a decellularizing agent at an acid pH to remove at least a portion of the cellular material therefrom and to yield a product comprising a liquid component and a solid component, subjecting the liquid component and the solid component to a plurality of filters, F1 through Fn, wherein n may be 2, or an integer higher than 2, wherein the pore sizes of the filter F1 through Fn range from 200 microns to 10 Kilo Daltons, yielding filtrates and retentates, recycling either of said filtrates or said retentates or both, either separately or together, to any of steps b) or c) or both, at least one time, and isolating a decellularized small particle tissue from any of steps of the process. Both the product and process are novel.Type: ApplicationFiled: June 20, 2013Publication date: October 31, 2013Inventor: Edmund Burke
-
Patent number: 8568730Abstract: The present invention provides compounds and methods for treating or preventing pulmonary diseases include COPD and asthma. In particular, the present invention provides for compounds comprising type V collagen, or tolerizing fragments thereof, for the treatment of COPD and asthma.Type: GrantFiled: April 22, 2010Date of Patent: October 29, 2013Assignee: Indiana University Research & Technology CorporationInventor: David S. Wilkes
-
Publication number: 20130273017Abstract: Methods and devices for the repair of articular tissue using collagen material are provided. Compositions of collagen material and related kits are also provided.Type: ApplicationFiled: April 15, 2013Publication date: October 17, 2013Inventor: Martha M. Murray
-
Publication number: 20130272997Abstract: A biocompatible, polymeric composition is disclosed. The composition comprises a base polymer comprising (i) a prepolymer comprising para-dioxanone (PDO) and trimethylene carbonate (TMC); and (ii) an end-graft polymer chain comprising a polylactone. Also disclosed are a method for treating bleeding from bone or bony structures using the composition, a method for filling a void or correct a defect in a bone using the composition, and a method for producing the biocompatible, polymeric composition of the present application.Type: ApplicationFiled: April 12, 2012Publication date: October 17, 2013Applicant: Poly-Med, Inc.Inventors: Kenneth David Gray, JR., Michael Scott Taylor
-
Publication number: 20130266638Abstract: Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that is alleviated by inhibiting such 3DG production. Methods of using such compositions, e.g., for improving the appearance, texture and/or elasticity of aging skin, are also disclosed.Type: ApplicationFiled: June 3, 2013Publication date: October 10, 2013Inventors: Annette Tobia, Alice Marcy, Bangying Su, Takeshi Niwa
-
Publication number: 20130259915Abstract: A composition for the treatment of skin comprises a non-emulsified, aqueous suspension of retinol. The composition may further include at least one protein species, and some proteins used in the composition include collagen and elastin. The composition may also include hyaluronic acid. The composition may also include one or more of tocopheryl acetate, propylene glycol, and linseed extract. Also disclosed are methods for making the composition and use of the composition for the treatment of skin.Type: ApplicationFiled: May 28, 2013Publication date: October 3, 2013Inventor: Elliott Milstein
-
SHAPED BODY WITH COLLAGEN-CONTAINING COMPOSITE MATERIAL FOR INTRODUCTION INTO A BONE DEFECT LOCATION
Publication number: 20130251755Abstract: The shaped body is intended for introduction into an alveolar space or into another bone defect location. A composite material with at least a first material component in the form of a collagen material and a second material component in the form of a bone replacement material is provided for the shaped body. The collagen material forms a matrix, in which the bone replacement material is embedded, distributed non-homogeneously, so that a local collagen proportion based on any desired part volume of 30 mm3 is at least 10% everywhere and a global collagen proportion based on the total volume is in the range between 30% and 95%. The shaped body is compressible. A local bone replacement proportion based, in each case, on a part volume of 30 mm3 has its maximum value at an edge face and decreases inwardly proceeding from the edge face, a BRM zone provided with bone replacement material extending into the interior proceeding from the edge face.Type: ApplicationFiled: September 18, 2012Publication date: September 26, 2013Applicant: Resorba Wundversrgung GmbH & Co. KGInventors: Markus FREY, Michael Ahlers, Karl-Heinz Sorg, Christian Huber -
Publication number: 20130252900Abstract: Provided herein, for example, are microspheres comprising a gelatin or gelatin substitute and a copolymer of a N-tris-hydroxymethyl methylacrylamide monomer unit, a diethylaminoethylacrylamide monomer unit and a N,N-methylene-bis-acrylamide monomer unit. Also provided are methods of producing microspheres comprising a gelatin or gelatin substitute and a copolymer of a N-tris-hydroxymethyl methylacrylamide monomer unit, a diethylaminoethylacrylamide monomer unit and a N,N-methylene-bis-acrylamide monomer unit. Further provided herein, for example, are compositions comprising the microspheres and methods of using the microspheres and compositions thereof.Type: ApplicationFiled: May 8, 2013Publication date: September 26, 2013Applicant: Biosphere Medical, SAInventors: Philippe Reb, Marion Pierre, Barbara De Gioannis, James Krom
-
Publication number: 20130252899Abstract: The invention relates to a collagen hydrolysate for use to improve the health of human skin, hair and/or nails, at least 90% by weight of the collagen hydrolysate having a molecular weight of less than 3,500 Da and the collagen hydrolysate comprising at least four characteristic peptides with a molecular weight between 600 and 1,200 Da.Type: ApplicationFiled: May 7, 2013Publication date: September 26, 2013Inventors: Stephan HAUSMANNS, Monika GIESEN-WIESE, Steffen OESSER
-
Patent number: 8541372Abstract: Described are purified extracellular matrix materials isolated from the abdominal wall of animals and including the subserous fascia layer of the abdominal wall. Such medical materials can find use in treating damaged tissue and in certain aspects in providing tissue support for the repair of hernias. Related methods of manufacture and use are also described.Type: GrantFiled: January 3, 2011Date of Patent: September 24, 2013Assignee: Cook Biotech IncorporatedInventors: Bhavin Shah, Katie L. Harrigan
-
Publication number: 20130245528Abstract: Provided herein is a topical wound dressing that comprises a collagen and a flexible paste. Also provided is a wound dressing with a first layer of a sterilized mixture of collagen and a second adhesive layer effective to adhere to surrounding skin and to keep the first layer in contact with the wound. In addition there is provided a wound dressing foil that comprises collagen and a plastic compound that can provide a foil shape. Furthermore, methods of dressing wounds utilizing the wound dressings and wound dressing foil are provided herein.Type: ApplicationFiled: March 13, 2013Publication date: September 19, 2013Inventor: Carl Randall Harrell
-
Publication number: 20130244943Abstract: Hydrogels comprising a macromolecular matrix and water may be used for aesthetic fillers, for example, dermal fillers. The macromolecular matrix may include a crosslinked combination of hyaluronic acid and collagen.Type: ApplicationFiled: November 2, 2012Publication date: September 19, 2013Applicant: ALLERGAN, INC.Inventors: Xiaojie Yu, Nicholas J. Manesis, Jacob Pollock
-
Publication number: 20130243822Abstract: This invention provides compositions and methods for topically treating skin wounds. The composition comprises C7, C7M, a variant thereof, or a combination thereof in a pharmaceutically acceptable carrier. The method comprises the steps of topically applying compositions of this invention to the skin wound.Type: ApplicationFiled: September 11, 2012Publication date: September 19, 2013Applicant: UNIVERSITY OF SOUTHERN CALIFORNIAInventors: Mei Chen, David Woodley
-
Publication number: 20130237486Abstract: The present invention relates to a trimeric fusion protein comprising three polypeptide chains, wherein each polypeptide chain comprises a eukaryotic collagen or collagen-like domain and a prokaryotic or viral trimerisation domain (PVTD). Also provided is a fusion polypeptide comprising a eukaryotic collagen or collagen-like domain and a PVTD. A suitable PVTD of a fusion polypeptide or protein of the invention is preferably derived from a collagen-like protein sequence found in the genome of the E. coli strain O157:H7 and other E. coli strains, and in bacteriophages or prophages infecting these strains or embedded in their genomes. A PVTD mediates trimerisation of collagen or collagen like polypeptides.Type: ApplicationFiled: November 14, 2011Publication date: September 12, 2013Applicant: The University of ManchesterInventor: Jordi Bella
-
Publication number: 20130237485Abstract: This invention discloses a method of inducing expression of full-length collagen 7 in cells that contain nonsense mutations in the COL7A1 gene by treating the cell with an aminoglycoside such as G418, gentamicin, and paromomycin. Also provided is a method of treating DEB due to nonsense mutation in the COL7A1 gene by administering a composition containing an effective amount of an aminoglycoside. Also provided is a novel composition useful to treating conditions due to nonsense mutation in the COL7A1 gene, containing an aminoglycoside, a C7, a min-C7 or both; and a pharmaceutically acceptable carrier.Type: ApplicationFiled: May 6, 2011Publication date: September 12, 2013Applicant: UNIVERSITY OF SOUTHERN CALIFORNIAInventors: Mei Chen, David Woodley
-
Publication number: 20130231288Abstract: The present invention provides compositions comprising human placental telopeptide collagen, methods of preparing the compositions, methods of their use and kits comprising the compositions. The compositions, kits and methods are useful, for example, for augmenting or replacing tissue of a mammal.Type: ApplicationFiled: February 26, 2013Publication date: September 5, 2013Applicant: Anthrogenesis CorporationInventors: Mohit Bhatia, Chris Lugo, Qian Ye, James W. Edinger
-
Publication number: 20130230573Abstract: A method of fabricating a collagen structure, is disclosed. The method comprises applying onto a surface in a layerwise manner acidic solutions of liquid crystalline collagen and a crosslinker to form a layered structure. The acidic solutions that correspond to at least two adjacent layers have different concentrations of the crosslinker therein.Type: ApplicationFiled: November 16, 2011Publication date: September 5, 2013Inventors: Oded Shoseyov, Amit Yaari
-
Publication number: 20130225497Abstract: A skin collagen production-promoting agent includes a milk protein fraction having following properties (a) to (c) as an active ingredient: (a) being derived from milk, (b) containing proteins having a molecular weight determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of 6000 to 150,000 daltons, and (c) containing 12 to 14 wt % of basic amino acids with respect to the constituent amino acid composition, and having a basic amino acid/acidic amino acid ratio of 0.5 to 0.7.Type: ApplicationFiled: September 29, 2011Publication date: August 29, 2013Applicant: MEGMILK SNOW BRAND CO., LTD.Inventors: Ken Kato, Aiko Ono, Hiroshi Ueno, Noriko Ueda, Hiroaki Matsuyama
-
Publication number: 20130217631Abstract: A collagen mixture having a portion of unhydrolyzed eggshell membrane collagen and Avian collagen.Type: ApplicationFiled: March 21, 2013Publication date: August 22, 2013Applicant: Molecular Biology International, Inc.Inventor: Molecular Biology International, Inc.
-
Patent number: 8506981Abstract: The present invention is directed to implantable compositions comprising substantially spherical bioactive glass particles.Type: GrantFiled: April 23, 2013Date of Patent: August 13, 2013Assignee: Synergy Biomedical LLPInventor: Mark D. Borden
-
Publication number: 20130195988Abstract: A vascular embolization gelling agent for sustained release of drugs for treating tumors having a drug and a drug carrier. The drugs are antitumor drugs. The drug carrier includes poloxamer polymer and polyvinylpyrrolidone or gel made of the combination, and may be purified before use. The drug carrier accounts for 5-65% of the gel. The particle size of the gel is in the range of 10 nm-150 ?m. The embolization agent is a liquid gel at normal temperature, to facilitate direct transcatheter injection, and is rapidly solidified to the gel state in body with the increase of the temperature; it is used to encapsulate different drugs on demand, and can achieve dual efficacy of embolization and drug treatment through local sustained release of the drug. The present invention can be used as the embolization agent for endovascular interventional therapy for transcatheter arterial chemoembolization of various benign and malignant tumors.Type: ApplicationFiled: March 8, 2013Publication date: August 1, 2013Applicant: Shanghai Cancer InstituteInventor: Shanghai Cancer Institute
-
Patent number: 8497023Abstract: An article comprising two chemically grafted polymer layers comprising a hydrogel layer and an end-functionalized polyurethane layer. The invention also includes methods of making and using the article.Type: GrantFiled: August 5, 2009Date of Patent: July 30, 2013Assignees: Biomimedica, Inc., Emergence Venture Partners, LLCInventors: David Myung, Lampros Kourtis, Robert Ward, Michael J. Jaasma, Keith McCrea
-
Publication number: 20130190246Abstract: This invention relates to collagen-binding synthetic peptidoglycans. More particularly, this invention relates to collagen-binding synthetic peptidoglycans for use in vascular intervention procedures. The invention also relates to kits comprising such collagen-binding synthetic peptidoglycans and catheters or stents.Type: ApplicationFiled: June 23, 2011Publication date: July 25, 2013Applicant: PURDUE RESEARCH FOUNDATIONInventors: John E. Paderi, Alyssa Panitch, Kinam Park, Katherine Stuart
-
Publication number: 20130190245Abstract: A light activated collagen-flavin composite layer incorporating riboflavin is applied as treatment for infected lesions caused by bacteria and as the consequence of surgical procedures. These composites have also been found to be strong tissue adhesives that are effective in closing and sealing wounds, fixation of grafts/ implants and anastomoses. Advantages include speed of closure, reduced infection due to the elimination of foreign matter, evidence of accelerated wound healing and the ease of use in complex surgery, especially when watertight seals, limited access or small repair size are important factors. The riboflavin in the collagen layer is exposed to light (e.g., light having a wavelength between 360-375 nm or 440-480 nm), decomposing the riboflavin to form reactive oxygen species (ROS). Strong crosslinks between the collagen composite and tissue results. In addition, similar exposures eradicate pathogens in the wound is eradicated resulting in a sterile wound.Type: ApplicationFiled: November 10, 2010Publication date: July 25, 2013Inventors: Barbara A. Soltz, Robert Soltz
-
Publication number: 20130189344Abstract: Human lubricating gels, methods and kits for delivering a therapeutic agent to a target tissue site beneath the skin of a patient utilizing human lubricating gel are provided, the human lubricating gel being capable of adhering to the target tissue site and comprising one or more biodegradable formulations containing an effective amount of the therapeutic agent. In various embodiments, the human lubricating gel is sprayable and hardens after contacting the target tissue site.Type: ApplicationFiled: January 23, 2012Publication date: July 25, 2013Applicant: Warsaw Orthopedic, Inc.Inventors: Susan J. Drapeau, Guobao Wei
-
Publication number: 20130178426Abstract: The invention has as its object the provision of a medicine capable of reducing a volume of emphysema-suffering pulmonary alveoli or alveolar sacs by means of a respiratory region volume inhibitor containing a coating film formation as a main component and capable of forming a coating film in a respiratory region, characterized by being used in such a way that the coating film-forming component is administered to an emphysema-suffering pulmonary alveolar parenchyma in a human-respiratory region in an amount of 0.004 to 200 g/application, preferably 0.07 to 20 g/application and more preferably 0.5 to 5 g/application on each occasion.Type: ApplicationFiled: August 10, 2011Publication date: July 11, 2013Applicant: Terumo Kabushiki KaishaInventors: Takao Anzai, Atsuhiko Nogawa, Yuichi Tada
-
Patent number: 8481480Abstract: Formulations having anti-adherent properties are disclosed herein. The anti-adherent formulation described herein acts to prevent the adherence of menses and/or fecal material to the skin in the labial and perianal regions during and after menstruation or defecation, respectively. The anti-adherent formulation contains a carrier, from about 0.1% by weight to about 10.0% by weight of a quaternary ammonium compound, and from about 0.5% by weight to about 10.0% by weight of a fatty alcohol. The anti-adherent formulation may be applied to the targeted surface either directly, in liquid form, such as by a spray bottle or similar packaging capable of delivering a liquid formulation in a relatively uniform amount over the full surface to be covered. Alternatively, the formulation may be applied to the targeted surface by a “wet” wipe or wiper.Type: GrantFiled: April 30, 2012Date of Patent: July 9, 2013Inventors: Uyen T. Lam, Kelly Laura Wolff, Corey T. Cunningham, Douglas R. Hoffman, Scott W. Wenzel
-
Patent number: 8481493Abstract: The invention relates to collagenous polypeptide films on which cells are cultivated. In particular the invention relates to such films that are used to treat wounds such as severe burns or physical or chemical injury. The invention also related to methods for producing such films.Type: GrantFiled: June 22, 2012Date of Patent: July 9, 2013Assignee: Fujifilm Manufacturing Europe B.V.Inventors: Raymond Lurvink, Peter Franciscus Theresius Maria van Asten, Jan Bastiaan Bouwstra, Sebastianus Gerardus Johannes Maria Kluijtmans
-
Publication number: 20130165384Abstract: A process for producing a decellularized small particle tissue which involves selecting an appropriate tissue starting material from which a decellularized small particle tissue is desired to be prepared, treating the tissue with a decellularizing agent at an acid pH to remove at least a portion of the cellular material therefrom and to yield a product comprising a liquid component and a solid component, subjecting the liquid component and the solid component to a plurality of filters, F1 through Fn, wherein n may be 2, or an integer higher than 2, wherein the pore sizes of the filter F1 through Fn range from 200 microns to 10 Kilo Daltons, yielding filtrates and resonates, recycling either of said filtrates or said retentates or both, either separately or together, to any of steps b) or c) or both, at least one time, and isolating a decellularized small particle tissue from any of steps of the process. Both the product and process are novel.Type: ApplicationFiled: December 14, 2012Publication date: June 27, 2013Inventor: Edmund Burke
-
Patent number: 8470774Abstract: Compositions and methods for inducing the deposition of elastin in skin by administering compositions including a mineralocorticoid, such as, for example, aldosterone and, optionally, a secondary active agent for enhancing or modulating the effect of the mineralocorticoid are described herein.Type: GrantFiled: February 27, 2012Date of Patent: June 25, 2013Assignees: Human Matrix Sciences, LLC, The Hospital for Sick ChildrenInventors: Aleksander Hinek, Thomas F. Mitts
-
Publication number: 20130157956Abstract: A crosslinked gelatin hydrogel composition for tissue augmentation.Type: ApplicationFiled: August 12, 2011Publication date: June 20, 2013Applicant: FUJIFILM MANUFACTURING EUROPE B.V.Inventors: Sebastianus Gerardus Kluijtmans, Annemarie Tuin, Marja Johanna Adriana Van Luyn, Martin Conrad Harmsen, Jan Bastiaan Bouwstra
-
Publication number: 20130156819Abstract: The present invention relates to peptides or fragments thereof, which peptides bind to mesenchymal stem cells. The present invention also relates to a method for identifying, isolating, specifically selecting and/or enriching mesenchymal stem cells, wherein the peptides, or fragments thereof, are employed for specifically binding to the mesenchymal stem cells. Also, the present invention relates to the use of the peptides of the invention, or fragments thereof, and of the mesenchymal stem cells isolated with the peptides of the invention, or fragments thereof, for treating, injuries and/or degenerated bone, cartilage or tissues.Type: ApplicationFiled: December 5, 2012Publication date: June 20, 2013Applicants: Baden-Württemberg Stiftung gGmbH, Eberhard-Karls-Universit°t Tübingen Universit°tsklinikumInventors: Eberhard-Karls-Universit°t Tübingen Universit°tskl, Baden-Württemberg Stiftung gGmbH
-
Publication number: 20130150305Abstract: The present invention discloses a method for treating wounds and for accelerating the healing of wounds by administering an effective amount of a pharmaceutical composition containing type VII collagen protein, mini-C7 protein, variants thereof or any combinations thereof. The pharmaceutical composition may be administered through a variety of routes including intravenous injection, topical application, or oral ingestion. The method may further include administering a genetically modified fibroblast capable of expressing type VII collagen protein, mini-C7 protein, variants thereof or small growth factors to achieve synergistic healing effect.Type: ApplicationFiled: October 22, 2012Publication date: June 13, 2013Inventors: Mei CHEN, David WOODLEY
-
Publication number: 20130142840Abstract: Method for preparing a homogeneous collagen-based material by concentration of a collagen solution, includes bringing a collagen solution into contact by way of continuous injection and use of the material for tissue repair.Type: ApplicationFiled: May 30, 2011Publication date: June 6, 2013Applicants: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), UNIVERSITE DE VERSAILLES SAINT QUENTIN EN YVELINES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEInventors: Marie-Madeleine Giraud-Guille, Nadine Nassif, Yan Wang, Christophe Helary, Anne Pelle
-
Publication number: 20130137640Abstract: A composition includes a food ingredient or nutrient with safety and experience having been eaten for a long time and that shows a collagen enhancing activity. The food ingredient or nutrient of the composition includes a skin collagen enhancing agent that includes menaquinone-7 as an active ingredient. The composition including skin collagen enhancing agent can be administered percutaneously or orally as a drug, a cosmetic, or a supplement.Type: ApplicationFiled: October 3, 2012Publication date: May 30, 2013Applicant: J-OIL MILLS, INC.Inventor: J-OIL MILLS, INC.
-
Patent number: 8450276Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the bending stiffness of scoliotic spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the scoliotic curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.Type: GrantFiled: June 16, 2010Date of Patent: May 28, 2013Assignee: Orthopeutics L.P.Inventor: Thomas P. Hedman
-
Patent number: 8450273Abstract: Fusion proteins containing active agonist or antagonist fragments of parathyroid hormone (PTH) and parathyroid hormone related peptide (PTHrP) coupled to a collagen-binding domain are presented. The fusion proteins can be used to promote bone growth, to promote hair growth, to prevent cancer metastasis to bone, to promote immune reconstitution with a bone marrow stem cell transplant, to promote mobilization of bone marrow stem cells for collection for autologous stem cell transplant, and to treat renal osteodystrophy. Pharmaceutical agents comprising a collagen-binding polypeptide segment linked to a non-peptidyl PTH/PTHrP receptor agonist or antagonist are also presented.Type: GrantFiled: April 9, 2008Date of Patent: May 28, 2013Assignees: The Board of Trustees of the University of Arkansas, Ochsner Clinic Foundation, National University Corporation Kagawa UniversityInventors: Joshua Sakon, Robert C. Gensure, Osamu Matsushita
-
Publication number: 20130129710Abstract: The invention discloses a method for producing a hemostatic composition comprising mixing a biocompatible polymer suitable for use in hemostasis and a genipin-type crosslinker, crosslinking said polymer by said genipin-type crosslinker to obtain a crosslinked biocompatible polymer, and finishing said crosslinks polymer to a pharmaceutically acceptable hemostatic composition, new hemostatic compositions and methods for using such compositions.Type: ApplicationFiled: October 25, 2012Publication date: May 23, 2013Applicants: Baxter Healthcare S.A., Baxter International Inc.Inventors: Baxter International Inc., Baxter Healthcare S.A.